In past years, several investigations have focused on heterocyclic structures, which are capable of inhibiting Hsp90 proteins, which are overexpressed in cancer or tumor cells, providing promising treatment strategies for cancer therapy with high targeting and efficiency. Here, HSP90AA1 is linked to cancer.